Literature DB >> 17083992

Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).

Hidetoshi Arima1, Yuko Chihara, Masayo Arizono, Shogo Yamashita, Koki Wada, Fumitoshi Hirayama, Kaneto Uekama.   

Abstract

To enhance gene transfer activity of dendrimers, we prepared its conjugate (generation 3, G3) with alpha-cyclodextrin bearing mannose (Man-alpha-CDE conjugates) with various degrees of substitution of the mannose moiety (DSM5, 10, 13, 20) and compared their cytotoxicity and gene transfer activity, and elucidated the enhancing mechanism for the activity. Of the various carriers used here, Man-alpha-CDE conjugate (G3, DSM10) provided the highest gene transfer activity in NR8383, A549, NIH3T3 and HepG2 cells, being independent of the expression of mannose receptors. Gene transfer activity of Man-alpha-CDE conjugate (G3, DSM10) was not decreased by the addition of 10% serum in A549 cells. Cytotoxicity of the polyplex with Man-alpha-CDE conjugates (G3, DSM10) was not observed in A549 and NIH3T3 cells up to the charge ratio of 200/1 (carrier/pDNA). The gel mobility and particle size of polyplex with Man-alpha-CDE conjugate (G3, DSM10) were relevant to those with alpha-CDE conjugate (G3), but zeta-potential, DNase I stability, pDNA condensation of the former polyplex were somewhat different from those of the latter one. Cellular association of polyplex with Man-alpha-CDE conjugate (G3, DSM10) was almost comparable to that with dendrimer (G3) complex and alpha-CDE conjugate (G3). The addition of mannan and mannose attenuated gene transfer activity of Man-alpha-CDE conjugate (G3, DSM10) in A549 cells. Alexa-pDNA complex with TRITC-Man-alpha-CDE conjugate (G3, DSM10), but not the complex with TRITC-alpha-CDE conjugate (G3), was found to translocate to nucleus at 24 h after incubation in A549 cells. HVJ-E vector including mannan, but neither the vector alone nor the vector including dextran, suppressed the nuclear localization of TRITC-Man-alpha-CDE conjugate (G3, DSM10) to a striking degree after 24 h incubation in A549 cells. These results suggest that Man-alpha-CDE conjugate (G3, DSM10) has less cytotoxicity and prominent gene transfer activity through not only its serum resistant and endosome-escaping abilities but also nuclear localization ability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083992     DOI: 10.1016/j.jconrel.2006.08.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

1.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

2.  Development of a successive targeting liposome with multi-ligand for efficient targeting gene delivery.

Authors:  Kun Ma; Haijun Shen; Song Shen; Men Xie; Chuanbin Mao; Liyan Qiu; Yi Jin
Journal:  J Gene Med       Date:  2011-05       Impact factor: 4.565

3.  In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.

Authors:  Ahmed Fouad Abdelwahab Mohammed; Taishi Higashi; Keiichi Motoyama; Ayumu Ohyama; Risako Onodera; Khaled Ali Khaled; Hatem Abdelmonsef Sarhan; Amal Kamal Hussein; Hidetoshi Arima
Journal:  AAPS J       Date:  2019-04-16       Impact factor: 4.009

4.  Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.

Authors:  Xiangji Chen; Shuping Dou; Guozheng Liu; Xinrong Liu; Yi Wang; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2008-07-23       Impact factor: 4.774

5.  Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama
Journal:  Sensors (Basel)       Date:  2009-08-17       Impact factor: 3.576

Review 6.  Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers.

Authors:  Hidetoshi Arima
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

7.  Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama; Taishi Higashi
Journal:  Pharmaceuticals (Basel)       Date:  2011-12-30

8.  Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama; Taishi Higashi
Journal:  Pharmaceutics       Date:  2012-02-01       Impact factor: 6.321

9.  All-in-one processing of heterogeneous human cell grafts for gene and cell therapy.

Authors:  Ekaterina Y Lukianova-Hleb; Eric S Yvon; Elizabeth J Shpall; Dmitri O Lapotko
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

10.  Synthesis, radiolabelling, and biological assessment of folic acid-conjugated G-3 99mTc-dendrimer as the breast cancer molecular imaging agent.

Authors:  Saedeh Zamani; Mehdi Shafeie-Ardestani; Ahmad Bitarafan-Rajabi; Ali Khalaj; Omid Sabzevari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.